Dr. Lloyd-Jones earned his BA from Swarthmore College, his MD from Columbia University College of Physicians and Surgeons, and a Master of Science degree in Epidemiology from the Harvard School of Public Health. He did his residency and served as Chief Resident in Medicine at Massachusetts General Hospital. After his cardiology fellowship at MGH, he was Instructor and then Assistant Professor of Medicine at Harvard Medical School. He moved to Northwestern University in 2004, and was appointed Chair of the Department of Preventive Medicine in 2009. He is the Eileen M. Foell Professor of Preventive Medicine and of Medicine. In 2012, he became director of the Northwestern University Clinical and Translational Sciences (NUCATS) Institute and PI of its CTSA award. Dr. Lloyd-Jones’ research interests lie in cardiovascular disease epidemiology, risk estimation, and prevention. A main focus of his NHLBI-funded research has been investigation of the lifetime risks for cardiovascular diseases. He was the first to describe the lifetime risks for many forms of CVD, and factors which modify those risks. Other areas of interest include CVD risk estimation using novel biomarkers, imaging of subclinical atherosclerosis, hypertension, dyslipidemia and prevention. His work in cardiovascular epidemiology and prevention has influenced numerous national and international guidelines in the prevention and treatment of CVD. He chaired the committee and authored the monograph that defined and set the American Heart Association’s Strategic Impact Goals for 2010-2020, including a bold new focus on cardiovascular health promotion. He has also chaired and co-authored numerous ACC/AHA clinical practice guidelines. He is a Fellow of the American College of Cardiology and the American Heart Association. Annually from 2014-2018, he has been named a Highly Cited Researcher (top 1% of cited authors) in the field of Clinical Medicine by Clarivate Analytics (Thomson Reuters).